Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-08

Clinical Trial Update: OSA Screen Negative With Spinal Duramorph [NA]

View source ↗

Summary

Clinical trial update for spinal duramorph in patients with risk of respiratory depression; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinal Duramorph (morphine sulfate (intrathecal))

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Respiratory Depression | NA | Status: TERMINATED | Results posted: 2018-03-08